These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36978160)

  • 21. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
    Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
    Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Optimized Version of the Positive and Negative Symptoms Scale (PANSS) for Pediatric Trials.
    Findling RL; Youngstrom EA; McClellan JM; Frazier JA; Sikich L; Daniel DG; Busner J
    J Am Acad Child Adolesc Psychiatry; 2023 Apr; 62(4):427-434. PubMed ID: 36526163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of the abbreviated version of the Scale to Assess Unawareness in Mental Disorder in schizophrenia.
    Michel P; Baumstarck K; Auquier P; Amador X; Dumas R; Fernandez J; Lancon C; Boyer L
    BMC Psychiatry; 2013 Sep; 13():229. PubMed ID: 24053640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Ludwig KA; Pinkham AE; Harvey PD; Kelsven S; Penn DL
    Schizophr Res; 2017 Dec; 190():136-143. PubMed ID: 28302395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of auditory hallucinations in patients with schizophrenia: A validation study of the Malay version of Psychotic Symptom Rating Scales (PSYRATS).
    Wahab S; Zakaria MN; Sidek D; Abdul Rahman AH; Shah SA; Abdul Wahab NA
    Psychiatry Res; 2015 Aug; 228(3):462-7. PubMed ID: 26142835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia.
    Lim K; Peh OH; Yang Z; Rekhi G; Rapisarda A; See YM; Rashid NAA; Ang MS; Lee SA; Sim K; Huang H; Lencz T; Lee J; Lam M
    Asian J Psychiatr; 2021 Aug; 62():102732. PubMed ID: 34118560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.
    Lambert M; Karow A; Leucht S; Schimmelmann BG; Naber D
    Dialogues Clin Neurosci; 2010; 12(3):393-407. PubMed ID: 20954433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Brief Negative Symptom Scale: Validation in a multicenter Brazilian study.
    de Medeiros HLV; Vasconcelos SC; Elkis H; Martins DR; de Alexandria Leite RM; de Albuquerque ACL; Freitas RR; Scardoelli MA; Di Sarno E; Napolitano I; Oliveira GM; Vizzotto A; da Silva AMP; da Costa Lima MD
    Compr Psychiatry; 2018 Aug; 85():42-47. PubMed ID: 29966891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first-episode psychosis?
    Langeveld J; Andreassen OA; Auestad B; Færden A; Hauge LJ; Joa I; Johannessen JO; Melle I; Rund BR; Røssberg JI; Simonsen E; Vaglum P; Larsen TK
    Scand J Psychol; 2013 Apr; 54(2):160-5. PubMed ID: 23252448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
    Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.